Share information

Efficient diagnostics for better treatment decisions

Gentian is a company listed on Euronext Oslo Børs as GENT.

Latest share price development, trade volumes and other share information can be found on Euronext.

A full overview of shareholders including nominee accounts in accordance with the SRDII requirements

was last updated per 16 February 2026 and is available upon request at invest@gentian.no

Top 20 shareholders

31.10.2026

Shareholder No of Shares %
DNB Bank ASA 2,110,224 13.65%
Kvantia AS 1,803,368 11.67%
Carpe Diem Afseth AS 1,007,500 6.52%
Norda ASA 716,099 4.63%
Safrino AS 649,700 4.20%
DNB Carnegie Investment Bank AB 645,743 4.18%
Insr ASA 614,251 3.97%
J.P. Morgan SE 600,000 3.88%
DNB Bank ASA, Meglerkonto Innland 571,169 3.69%
Verdipapirfondet Delphi Norge 389,572 2.52%
Intertrade Shipping AS 360,000 2.33%
Krefting, Johan Henrik 326,600 2.11%
Alfaplan AS 308,764 2.00%
Verdipapirfondet DNB Smb 302,636 1.96%
Manheim, Joachim Fasting 254,365 1.65%
Lioness AS 220,000 1.42%
Marstal AS 212,407 1.37%
T.D. Veen AS 195,000 1.26%
Skandinaviska Enskilda Banken AB 180,000 1.16%
Caaby AS 173,500 1.12%
Other Shareholders 3,817,726 24.70%
Total Shares 15 458 624 100 %

Primary insiders 

Name and position of primary insiders can be found on Euronext.

Gentian Diagnostics ASA - Prospectus

ACCESS HERE

IR Contact

Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525